1.1603
-0.0497
(-4.11%)
As of 12:37:46 PM EDT. Market Open.
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 3.09k | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
BITTERMAN ROBERT J Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 11, 2024 |
BRADFORD PATRICIA A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 11, 2024 |
LOCKSHIN CURTIS Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 11, 2024 |
FREEMAN JONATHAN E PH.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 11, 2024 |
FERRARA ROBERT L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 11, 2024 |
INFARINATO ROBERT M. ESQ., CPA Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 11, 2024 |
INFARINATO ROBERT M. ESQ., CPA Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 13, 2024 |
BITTERMAN ROBERT J Chief Executive Officer | Purchase at price 0.74 per share. | Direct | 740 | Jun 7, 2024 |
BITTERMAN ROBERT J Chief Executive Officer | Purchase at price 0.75 per share. | Direct | 750 | Jun 6, 2024 |
BITTERMAN ROBERT J Chief Executive Officer | Purchase at price 0.91 per share. | Direct | 2,275 | Feb 26, 2024 |
BITTERMAN ROBERT J Chief Executive Officer | Purchase at price 2.84 - 2.88 per share. | Direct | 5,720 | Jun 30, 2023 |
FERRARA ROBERT L Director | Purchase at price 3.10 per share. | Direct | 6,200 | Jun 14, 2023 |
Related Tickers
HOTH Hoth Therapeutics, Inc.
0.9363
-4.30%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.2600
-3.79%
REVB Revelation Biosciences, Inc.
2.8100
+7.66%
ENSC Ensysce Biosciences, Inc.
2.4500
-7.20%
SLRX Salarius Pharmaceuticals, Inc.
0.7790
+7.23%
SILO Silo Pharma, Inc.
1.0901
+0.94%
PALI Palisade Bio, Inc.
0.6500
-2.64%
ZVSA ZyVersa Therapeutics, Inc.
0.6283
+6.98%
ENVB Enveric Biosciences, Inc.
1.3000
-4.41%
APM Aptorum Group Limited
0.8300
-4.06%